Our regulatory affairs experts

Alice specialises in Regulatory Affairs, mainly for Europe, and is experienced in leading cross-functional projects across the full product life cycle, with a focus on pre-MAA and MAA activities. Her regulatory expertise also includes regulatory strategy and preparation of high-quality regulatory, scientific, and medical documentation. In addition, Alice has longstanding research experience in the cancer/growth control field.

She holds a PhD in Biology from UCL in London and a Master’s degree in Developmental Biology from Ecole Normale Supérieure/UPMC in Paris.

Alicia specialises in regulatory affairs and compliance review. She has valuable experience from the Swedish Association of the Pharmaceutical Industry (LIF), where she worked across regulatory affairs, pharmacovigilance, medical information, and market access. Alicia holds an MSc in Biochemistry from Stockholm University.

David specialises in Regulatory Affairs. His experience spans the full product lifecycle in both Swiss and EU markets. He led multiple successful Marketing Authorisation Applications, amongst others for oncology products, orphan medicinal products and Advanced Therapy Medicinal Products (ATMPs). He also has deep expertise in post-approval lifecycle management in the EU, Switzerland, and the UK. David holds a PhD in Neurobiology and an MSc in Molecular Biology from the University of Basel.

Marietta specialises in operational and customised Market Access and HTA projects for Switzerland, ensuring that evidence-based approaches support both patient outcomes and commercial success. She has several years of experience in Medical Affairs and Regulatory Affairs, especially in medical writing. Her most recent position was as Senior Manager in Medical affairs and Market Access at Veristat in Basel.

Marietta holds a PhD in Developmental Biology & Embryology from the University of Basel and an MSc in Molecular Biology from the University of Vienna.

Nathalie specialises in regulatory affairs in Switzerland, the UK, and the EU. She has successfully led and supported multiple Marketing Authorisation Applications (MAAs), including those for orphan and oncology products. Her expertise spans preMAA regulatory strategy work, through to MAA preparation and submission. Nathalie is also experienced in post-approval lifecycle management. She holds a PhD in Neurobiology and an MSc in Molecular Biology from the University of Basel.

Tytti specialises in pharmacovigilance and regulatory affairs. She has a master’s degree in Pharmaceutical Science from Umeå University, and her master thesis was conducted at the University of Copenhagen. Prior to joining Arex, Tytti worked as a Pharmacist Consultant.